Cognitive-behavioral therapy for medication-resistant schizophrenia: A review

Journal of Psychiatric Practice

Volumn 14, Issue 1, 2008, Pages 22-33

  Rathod, Shanaya ^a   Kingdon, David ^b   Weiden, Peter ^c   Turkington, Douglas ^d  

^a Mid Hampshire and Eastleigh TVS Locality   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Antipsychotic medication; Cognitive behavioral therapy (CBT); Delusions; Hallucinations; Persistent symptoms; Psychosis; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ANXIETY; COGNITION; COGNITIVE THERAPY; DELUSION; DEPRESSION; EMBASE; FOLLOW UP; HALLUCINATION; HUMAN; MEDLINE; PRACTICE GUIDELINE; PSYCHOLOGICAL RATING SCALE; PSYCHOSIS; PSYCINFO; RATING SCALE; REVIEW; SCHIZOPHRENIA; THOUGHT DISORDER; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; COGNITION DISORDERS; COGNITIVE THERAPY; DELUSIONS; DRUG RESISTANCE; FEMALE; HALLUCINATIONS; HUMANS; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; THINKING;

EID: 38549136737     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000308492.93003.db     Document Type: Review

References (93)

1. Kane M. Treatment resistant schizophrenic patients. J Clin Psychiatry 1996;57:35-40.
2. Kane M. Management strategies for the treatment of schizophrenia. J Clin Psychiatry 1999;60:13-7.
3. Pantelis C, Barnes TRE. Drug strategies in treatment resistant schizophrenia. Aust N Z J Psychiatry 1996;30:20-37.
4. Harrow M, Rattenbury F, Stoll F. Schizophrenic delusions: An analysis of their persistence, of related premorbid ideas and of three major dimensions In: Oltmanns TF, Maher BA, eds. Delusional beliefs. New York:Wiley; 1988:184-211.
5. Garety P, Hemsley D. Characteristics of delusional experience. Eur Arch Psychiatry Neurol Sci 1987;236:294-8.
6. Johnstone EC, Owens DG, Frith CD, et al. Clinical findings: Abnormalities of mental state and their correlates. The Northwick Park followup study. Br J Psychiatry 1991;159:21-5.
7. Briera A, Schreiber JL, Dyder J, et al. NIMH longitudinal study of chronic schizophrenics: Prognosis and predictors of outcome. Arch Gen Psychiatry 1991;48:239-46.
8. Tarrier N, Yusupoff L, Kinney C, et al. randomized controlled trial of intensive cognitive behavior therapy for patients with chronic schizophrenia. Br Med J 1998;317:303-7.
9. Sensky T, Turkington D, Kingdon D, et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Arch Gen Psychiatry 2000;57:165-72.
10. Turkington D, Kingdon D, Turner T. The effectiveness of a brief cognitive behavioral intervention in schizophrenia. Br J Psychiatry 2002;180:523-7.
11. Kemp R, Hayward P, Applewhaite G, et al. Compliance therapy in psychotic patients: A randomized controlled trial. Br Med J 1996;312:345-9.
12. Rathod S, Kingdon D, Smith P, et al. Insight into schizophrenia: The effects of cognitive behavioral therapy on the components of insight and association with sociodemographics: Data on a previously published randomized controlled trial. Schizophr Res 2005;74:211-9.
13. Knapp M, Healey A. Economic evaluation of psychological treatments for schizophrenia. In: Wykes T, Tarrier N, Lewis S, eds. Outcome and innovation in psychological treatment of schizophrenia. Chichester: Wiley; 1998:259-82.
14. Wykes T, Reeder C, Corner J, et al. The effects of neurocognitive remediation on executive processing in patients with schizophrenia. Schizophr Bull 1999;25:291-308.
15. Murray R. New ways of thinking about and treating psychosis. Keynote lecture at the third Latest Advances in Psychiatry symposium, March, 2004. Prog Neurol Psychiatry 2004;8:20-6.
16. Arseneault L, Cannon M, Poulton R, et al. Cannabis use in adolescence and risk for adult psychosis: Longitudinal perspective study. Br Med J 2002;325:212-39.
17. Sartorius N, Jablensky A, Shapiro R. Two year followup of the patients included in the WHO International Pilot Study of Schizophrenia. Psychol Med 1977;7:529-41.
18. Shallice T. From neuropsychology to mental structure. Cambridge: Cambridge University Press; 1988.
19. Pantelis C, Nelson H. Cognitive functioning and symptomatology in schizophrenia. In: David AS, Cutting J, eds. The neuropsychology of schizophrenia. London: Erlbaum; 1993:215-30.
20. Frith CD. The positive and negative symptoms of schizophrenia reflect impairments in the perception and initiation of action. Psychol Med 1987;17:631-48.
21. Frith CD. The cognitive neuropsychology of schizophrenia. Hove: Lawrence Erlbaum; 1992.
22. Hemsley D. Psychological treatment of schizophrenia. In: Lindsay S, Powell G, eds. Handbook of clinical psychology. London: Gower; 1986:309-28.
23. Hemsley D. Perceptual and cognitive abnormalities as the basis for schizophrenic symptoms. In: David AS, Cutting J, eds. The neuropsychology of schizophrenia. London: Erlbaum; 1994:97-116.
24. Zubin J, Spring B. Vulnerability: A new view on schizophrenia. J Abnorm Psychol 1977;86:103-26.
25. Kingdon DG, Turkington D. Cognitive therapy of schizophrenia. Guide to individualized evidence-based treatment. Persons J, series ed. New York: Guilford; 2005.
26. Turkington D, Siddle R. Cognitive therapy for the treatment of delusions. Adv Psychiatr Treat 1998;4:235-42.
27. Bentall RP, Kinderman P. Psychological processes and delusional beliefs: Implications for the treatment of paranoid states. In: Wykes T, Tarrier N, Lewis S, eds. Outcome and innovation in the psychological treatment of schizophrenia. Chichester: Wiley; 1998:119-44.
28. Kingdon D, Turkington D. Cognitive behavioral therapy for schizophrenia. Hove: Lawrence Erlbaum; 1994.
29. Fowler D, Garety P, Kuipers E. Cognitive behaviour therapy for psychosis. Chichester: John Wiley & Sons; 1995.
30. Chadwick PDJ, Birchwood M, Trower P. Cognitive therapy for delusions, voices and paranoia. Chichester: John Wiley & Sons; 1996.
31. Jaspers K. General psychopathology. Hoenig J, Hamilton MN, trans. Manchester: Manchester University Press; 1963.
32. Sachs MH, Carpenter WT, Srauss JS. Recovery from delusions. Arch Gen Psychiatry 1974;30:117-20.
33. Maher BA. Anomalous experience and delusional thinking: The logic of explanations. In: Oltmanns TF, Maher BA, eds. Delusional beliefs. New York: John Wiley & Sons; 1988;15-33.
34. Garety P, Hemsley DR. Delusions: Investigations into the psychology of delusional reasoning. Maudsley Monograph. Oxford: Oxford University Press; 1994.
35. Garety P, Kuipers E, Fowler D, et al. Cognitive model of the positive symptoms of psychosis. Psychol Med 2001;31:189-95.
36. Beck AT, Rector NA. Delusions: A cognitive perspective. Journal of Cognitive Psychotherapy 2002;16:455-68.
37. Hoffman R. Verbal hallucinations and language production processes in schizophrenia. Behav Brain Sci 1986;9:503-48.
38. David A. The neuropsychological origin of auditory hallucinations. In: David A, Cutting J, eds. The neuropsychology of schizophrenia. Hove: Erlbaum; 1994:269-316.
39. Bentall R. The illusion of reality: A review and integration of psychological research on hallucinations. Psychol Bull 1990;107:82-95.
40. McGuire P, Shah G, Murray M. Increased blood flow in Broca's area during auditory hallucinations in schizophrenia. Lancet 1993;342:703-6.
41. Shergill S, Brammer M, Fukuda R, et al. Modulation of activity in temporal cortex during generation of inner speech. Hum Brain Mapp 2002;16:219-27.
42. Freeman D, Garety P, Kuiper E, et al. Acting on persecutory delusions: The importance of safety seeking. Behav Res Ther 2007;45:89-99.
43. Hamilton M. Fish's schizophrenia. Bristol: John Wright & Sons; 1976.
44. Barnes T, Curson D, Liddle P, et al. The nature and prevalence of depression in chronic schizophrenic inpatients. Br J Psychiatry 1989;154:486-92.
45. Cassano G, Pini S, Saettoni M, et al. Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders. J Clin Psychiatry1998;59:60-8.
46. Birchwood MJ, Iqbal Z. Depression and suicidal thinking in psychosis: A cognitive approach. In: Wykes T, Tarrier N, Lewis S, eds. Outcomes and innovation in psychological treatment of schizophrenia. New York: John Wiley; 1998:81-100.
47. Harrow M, Prosen M. Intermingling and disordered logic as influences on schizophrenic "thought disorders." Arch Gen Psychiatry 1978;35:1213-8.
48. Beck AT. Successful outpatient psychotherapy of a chronic schizophrenic with a delusion based on borrowed guilt. Psychiatry 1952;15:305-12.
49. Hole RW, Rush AJ, Beck AT. A cognitive investigation of schizophrenic delusions. Psychiatry 1979; 42:312-9.
50. Fowler D, Morley S. The cognitive behavioral treatment of hallucinations and delusions: A preliminary study. behavioral Psychotherapy 1989;17:267-82.
51. Chadwick P, Lowe C. Measurement and modification of delusional beliefs. J Consult Clin Psychol 1990;58:225-32.
52. Roberts GA. Delusional systems and meaning in life - A preferred reality? Br J Psychiatry 1991;14:20-9.
53. Tarrier N, Beckett R, Harwood S, et al. A trial of two cognitive behavioral methods of treating drug resistant residual symptoms in schizophrenic peoples: I. Outcome. Br J Psychiatry 1993;162:524-32.
54. Krawiecka M, Goldberg G, Vaughan M. A standardized psychiatric assessment for rating chronic psychiatric patients. Acta Psychiatr Scand 1977;55:299-308.
55. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale (BPRS): Recent developments in ascertainment and scaling. Psychopharmacol Bull 1988;24:97-9.
56. Kuipers E, Garety P, Fowler D, et al. London-East Anglia randomized controlled trial of cognitive-behavioral therapy for psychosis, 1: Effects of the treatment phase. Br J Psychiatry 1997;171:319-27.
57. Haddock G, Bentall RP, Slade PD. Psychological treatment of auditory hallucinations: Focusing or distraction? In: Haddock G, Slade PD, eds. Cognitive behavioral interventions with psychotic disorders. London: Routledge; 1996:45-70.
58. Garety P, Kuipers L, Fowler D, et al. Cognitive behaviour therapy for drug resistant psychosis. Br J Med Psychol 1994;67:259-71.
59. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
60. Bouchard S, Vallieres A, Roy M, et al. Cognitive restructuring in the treatment of psychotic symptoms of schizophrenia: A critical analysis. Behav Ther 1996;27:257-77.
61. Garety P, Fowler D, Kuipers E, et al. London-East Anglia randomized controlled trial of cognitive-behavioral therapy for psychosis: II. Predictors of outcome. Br J Psychiatry 1997;171:420-6.
62. Kuipers E, Fowler D, Garety P, et al. London-East Anglia randomized controlled trial of cognitive-behavioral therapy for psychosis: III. Follow-up and economic evaluation at 18 months. Br J Psychiatry 1998;173:61-8.
63. Tarrier N, Wittkowski A, Kinney C, et al. Durability of the effects of cognitive-behavioral therapy in the treatment of schizophrenia: 12-month follow-up. Br J Psychiatry 1999;174:500-4.
64. Tarrier N, Kinney C, McCarthy E, et al. Two-year follow-up of cognitive-behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. J Consult Clin Psychol 2000; 68:917-22.
65. Pinto A, La Pia S, Mennella R, et al. Cognitive-behavioral therapy for clozapine clients with treatment-refractory schizophrenia. Psychiatr Serv 1999;50:901-4.
66. Andreasen N. Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, IA: University of Iowa; 1984.
67. Andreasen N. Scale for the Assessment of Negative Symptoms (SANS). Iowa City, IA: University of Iowa; 1983.
68. Rector NA, Seeman MV, Segal ZV. Cognitive therapy of schizophrenia: A preliminary randomized controlled trial. Schizophr Res 2003;63:1-11.
69. Temple S, Ho B. Cognitive therapy for persistent psychosis in schizophrenia: A case-controlled clinical trial. Schizophr Res 2005;74:195-9.
70. Guy W. ECDEU assessment manual for psychopharmacology-revised (DHEW Publ. No ADM 76-338). Rockville, MD: U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs 1976: 218-22.
71. Endicott J, Spitzer RL, Fleiss JL, et al. The Global Assessment Scale: A procedure for measuring overall severity of psychiatry disturbance. Arch Gen Psychiatry 1976;33:766-71.
72. Cather C, Penn D, Otto MW, et al. A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophr Res 2005;74:201-9.
73. Granholm E, McQuaid J, McClure F, et al. A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia. Am J Psychiatry 2005;162:520-9.
74. Valmaggia L, Van der Gaag M, Tarrier N, et al. Cognitive behaviour therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication: randomized controlled trial. Br J Psychiatry 2005;186: 324-30.
75. Norman R, Townsend L. Cognitive behaviour therapy for psychosis: A status report. Can J Psychiatry 1999;44:245-52.
76. Garety P, Fowler D, Kuipers E. Cognitive behaviour therapy for medication resistant symptoms. Schizophr Bull 2000;26:73-86.
77. Dickerson FB. Cognitive behavioral psychotherapy for schizophrenia: A review of recent empirical studies. Schizophr Res 2000;43:71-90.
78. Dickerson F. Update on cognitive behavioral psychotherapy for schizophrenia: Review of recent studies. Journal of Cognitive Psychotherapy 2004;18:189-205.
79. Turkington D, Dudley R, Warman D, et al. Cognitive-behavioral therapy for schizophrenia: A review. J Psychiatr Pract 2004;10:5-16.
80. Rathod S, Turkington D. Cognitive behaviour therapy for schizophrenia: A review. Curr Opin Psychiatry 2005;18:159-63.
81. Gaudiano BA. Cognitive behavior therapies for psychotic disorders: Current empirical status and future directions. Clin Psychol 2005;12:33-50.
82. Zimmermann G., Favrod J, Trieu VH, et al. The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders: A meta-analysis. Schizophr Res 2005;77:1-9.
83. Rector N, Beck A. Cognitive behavioral therapy for schizophrenia: An empirical review. J Nerv Ment Dis 2001;189: 278-87.
84. Pilling S, Bebbington P, Kuipers E, et al. Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behavior therapy. Psychol Med 2002;32: 763-82.
85. National Institute for Clinical Excellence: Clinical guideline 1: Schizophrenia. Core interventions in the treatment and management of schizophrenia in primary and secondary care. London: NICE; 2002.
86. Gould RA, Mueser KT, Bolton E, et al. Cognitive therapy for psychosis in schizophrenia: An effect size analysis. Schizophr Res 2001;48:335-42.
87. Tarrier N, Wykes T. Is there evidence that cognitive behaviour therapy is an effective treatment for schizophrenia? A cautious or cautionary tale? Behav Res Ther. 2004;42:1377-1401.
88. Pfammatter M, Junghan UM, Brenner HD. Efficacy of psychological therapy in schizophrenia: Conclusions from meta-analyses. Schizophr Bull. 2006;32:564-80.
89. Paley G, Shapiro D. Lessons from psychotherapy research for psychological interventions for people with schizophrenia. Psychol Psychother 2002;75:5-7.
90. Christie-Smith D, Gartner C. Highlights of the 2002 Institute on Psychiatric Services. Psychiatr Serv 2003;54:12-17.
91. Turkington D, Kingdon D, Weiden P. Cognitive behaviour therapy for schizophrenia. Am J Psychiatry 2006;163:365-73.
92. Morrison AP, Bentall RP, French P, et al. Randomized controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high-risk individuals. Study design and interim analysis of transition rate and psychological risk factors. Br J Psychiatry 2002;43:78-84.
93. McGorry PD, Yung AR, Phillips LJ, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 2002;59:921-8.